How are we responding to the COVID-19 pandemic?

The National Clinician Consultation Center is pleased to support ongoing efforts to prevent, prepare for, and respond to COVID-19 as it relates to HIV and viral hepatitis prevention and treatment, as well as substance use disorder treatment. For more information on how we can assist you, please visit our COVID-19 Response Page.


HIV/AIDS Management

Expert clinical advice on providing optimal care to your HIV-positive patients, from initiating antiretroviral regimens to managing HIV/AIDS and comorbidities.
HIV/AIDS Guidelines »
Antiretroviral Drug Tables »

Perinatal HIV/AIDS

Immediate advice on HIV management in pregnant women and their infants, including referral to care.

Perinatal ReproID HIV Listserv »

Hepatitis C Management

Expert clinical advice on HCV testing, staging, monitoring, and treatment including hepatitis C mono- and co-infection.

Substance Use Management

Expert clinical advice for healthcare providers on substance use evaluation and management.

National Substance Use Warmline »
California Substance Use Line »

PEP: Post-Exposure Prophylaxis

Expert advice on managing occupational and non-occupational exposures to HIV and hepatitis B & C.

Online PEP Quick Guide »

PrEP: Pre-Exposure Prophylaxis

Up-to-date clinical advice on providing PrEP as a prevention tool, from determining when prescribing PrEP is appropriate to understanding follow-up tests.

Resources for Patients

The CCC provides consultation to assist healthcare providers only. If you are a patient who may have sustained an exposure to HIV or hepatitis B or C, please proceed to your nearest urgent or emergency medical facility. If you have questions about your own or a family member’s HIV care, please have your provider contact us directly, or contact one of the following patient resources. More information is available on our Resources for Patients page.